# Phase 8 — Multi-Agent Analyst Desk

**Ticker:** BABA
**As-of date:** 2026-05-20 (data: 2026-05-19)
**Generated:** 2026-05-20T01:15:00Z
**Upstream phases cited:** phase-1-flow.md, phase-2-dark-pool.md, phase-3-positioning.md, phase-4-structure.md, phase-5-historical.md, phase-6-macro.md, phase-7-insights.md
**Spot reference:** $135.69

## Summary

Four sub-agents ran in parallel; **earnings-scout was N/A** (next earnings
2026-09-04 = 107 DTE, well outside the 14–30d window the agent scans). The
desk returned a **split verdict: 2 RANGE / 1 SHORT (high conviction) / 1
LONG**. Notably, **all four agents converged on the exact same key levels**:
**support $133–$134.50, resistance $140, invalidation below $130 (trapdoor)
or sustained breakout above $140.50–$142**. The disagreement is purely about
*which side of the range* dominates next: the contrarian believes the
phase-5 6.7% backtest + complacent skew = a fade, while the sweep-tracker
believes the $217M 5-day persistence overwhelms the historical base rate. The
accumulation-hunter and risk-monitor both default to RANGE because the data
genuinely doesn't pick a side, and the risk-monitor explicitly recommends
**HALF-size position with no naked longs into 5/22 OPEX**. Average conviction
across the four agents is **2.75** — modest.

## Agent verdicts table

| Agent | Bias | Conviction | Horizon | One-line take |
|-------|------|:---------:|---------|---------------|
| accumulation-hunter | RANGE | 3 | 1–5d | No clean accumulation fingerprint — DPs sold the $140s, dealers pinned $135 ZGL, bullish_flow backtest 6.7%; range, not stealth bid. |
| contrarian-scanner | **SHORT** | **4** | 1–5d | Crowd buying calls into $140 gamma ceiling with no put hedges and 1-in-15 win-rate signature — fade the euphoria. |
| sweep-tracker | LONG | 3 | 1–5d | Tape screaming aggressive ASK call sweeps with persistent multi-day footprint, but $140 GEX wall + covered-call writers cap squeeze near-term. |
| risk-monitor | RANGE | 2 | 1–5d | Transitional regime, complacent skew, failed bullish-flow backtest — size HALF normal, no naked longs into 5/22 OPEX, treat as one slot of a China-tech basket. |
| earnings-scout | N/A | — | — | SKIPPED — next earnings 2026-09-04, 107 DTE, out of 14–30d window. |

## Per-agent details

### accumulation-hunter (RANGE, conv 3)

```
VERDICT
- bias: RANGE
- conviction: 3
- horizon: 1-5d
- key_levels:
    support: 133.40
    resistance: 140.00
    invalidation: close below 130.00 (trapdoor GEX) or above 140.50 (breaks call wall)
- top_signal: Phase 2 dark pool shows $88.5M overhead distribution at
  $140.87/$145.81/$144.15 vs only $3.4M net block buying today — institutions
  distributed out, not accumulating into.
- top_risk: 22 consecutive OI build days plus $2.43M Jan27 $150C ASK sweep
  could be slow stealth accumulation that front-runs the Ant IPO catalyst,
  breaking the range up.
- one_line_take: No clean accumulation fingerprint — dark pools sold the
  $140s, dealers pinned at $135 ZGL, and the bullish_flow signal backtest
  just printed 6.7% wins; this is range, not stealth bid.
```

### contrarian-scanner (SHORT, conv 4)

```
VERDICT
- bias: SHORT
- conviction: 4
- horizon: 1-5d
- key_levels:
    support: 133.40
    resistance: 140.00
    invalidation: sustained close above $140.87 with GEX flip to negative
- top_signal: Phase 5 backtest — bullish_flow signal hit 6.7% win rate
  (1/15) over 20 days with avg −1.62% move, while Phase 4 shows complacent
  25Δ skew (calls > puts +2.8 vol) confirming tail-of-greed positioning.
- top_risk: Phase 1 ASK-side $5.7M call sweeps + Mar 27 LEAP risk reversal
  could front-run a squeeze through the $140 GEX wall if macro tape
  stabilizes post-OPEX.
- one_line_take: Crowd is buying calls into a $140 gamma ceiling with no
  put hedges and a 1-in-15 win-rate signature — fade the euphoria.
```

### sweep-tracker (LONG, conv 3)

```
VERDICT
- bias: LONG
- conviction: 3
- horizon: 1-5d
- key_levels:
    support: 134.50
    resistance: 140.00
    invalidation: close below 132.50 or break of $130 trapdoor
- top_signal: Phase 1 sweep persistence 5/5 sessions consistency 1.0 with
  $5.69M ASK calls today led by Jan27 $150C $2.43M and Jun18 $139/138C
  200x+ vol/OI new money.
- top_risk: Phase 5 bullish_flow backtest is 6.7% win rate avg -1.62%, and
  Phase 3 May22 $137-142C ALL bid-skewed shows dealers/holders writing
  covered calls capping upside into 3DTE OPEX.
- one_line_take: Tape is screaming aggressive ASK call sweeps with
  persistent multi-day footprint, but $140 GEX wall and covered-call
  writers cap the squeeze near term.
```

### risk-monitor (RANGE, conv 2 — size HALF)

```
VERDICT
- bias: RANGE
- conviction: 2
- horizon: 1-5d
- key_levels:
    support: 133.00
    resistance: 140.00
    invalidation: close < 130.00 (trapdoor) or close > 142.00 (wall break + skew snap)
- top_signal: Phase 4 ZGL $135.66 pinned to spot $135.70 with $140 wall
  (+$8.5B) and $130 trapdoor (−$985M) — dealer structure forces compression
  into 5/22 OPEX.
- top_risk: Correlation stacking — BABA = China ADR + Cons Cyclical (sector
  −$27M) + AI-capex; adding to any long-risk book layers KWEB/BIDU/PDD/QQQ
  exposure, and Phase 5's 13 regime flips in 28 sessions plus 6.7%
  bullish-flow win rate means a single macro tape (CPI/oil/USDCNY) takes the
  whole cluster down with no skew cushion.
- one_line_take: Transitional regime, complacent skew, failed bullish-flow
  backtest — size HALF normal, no naked longs into 5/22 OPEX, and treat
  BABA as one slot of a China-tech basket not an independent bet.
```

### earnings-scout

**SKIPPED.** Next BABA earnings 2026-09-04 (107 DTE). The agent's window
is 14–30 days. Phase-6 already analyzed the May 13 print (rev miss,
non-GAAP profit −99.7%, Cloud +38%, −9% post-print). [AGENT:earnings-scout — N/A]

## Disagreements

The contrarian's **SHORT conviction-4** is the lone strong-bias dissent
against a default-RANGE majority + a default-LONG sweep-tracker. The
contrarian's argument is specifically the **Phase 5 backtest** plus the
**Phase 4 complacent skew** — both of which are factually present in the
data and not contradicted by phases 1–7. The sweep-tracker counter-cites
**Phase 1 5-day sweep persistence $217M** as evidence BABA is *exempt* from
the broader bullish_flow failure cohort.

The disagreement is genuine and unresolvable without a directional catalyst.
This is the structural condition the phase-9 trade plan must accommodate:
**a range-trade default with skew toward downside-protected long structures
(not naked longs)**.

## Tool errors

- earnings-scout skipped (intentional, not an error).
- No other tool errors.

## Verdict for downstream phases

- **Plurality bias:** **RANGE** (2 of 4). The lone-SHORT (contrarian) and
  lone-LONG (sweep-tracker) net out toward neutral. Phase 9 should adopt
  **range-trade default with defined-risk asymmetric structures**.
- **Average conviction:** **2.75 / 5** across 4 returning agents.
- **Three highest-quality signals across all agents:**
  1. **Phase 4 ZGL $135.66 / spot $135.70 / $140 wall (+$8.5B) / $130
     trapdoor (−$985M)** [STRUCT:gex] — cited by all 4 agents implicitly
     via key_levels; this is the desk consensus structural map.
  2. **Phase 5 bullish_flow win rate 6.7% (1/15), avg −1.62%**
     [HIST:signal_backtest] — cited by contrarian and risk-monitor as
     top_signal/top_risk; the single biggest down-vote on aggressive sizing.
  3. **Phase 1 $217M 5-day sweep persistence, consistency 1.0** with **Mar
     27 LEAP risk reversal + Jan 27 $150C $2.43M ASK** [FLOW:sweep_persistence]
     [FLOW:top_premium_trades] — cited by sweep-tracker and noted by
     accumulation-hunter; the single biggest reason BABA may be exempt from
     the broader failed-bullish-flow cohort.
- **Open questions surfaced by agents:**
  - Is the LEAP campaign front-running an **Ant IPO 2.0** catalyst in H2 2026?
    (accumulation-hunter top_risk) — phase 6 noted this as speculative; would
    flip the medium-term bias bullish if confirmed.
  - Could a post-5/22-OPEX **macro print (CPI / oil / USDCNY)** take the entire
    China-tech basket down together? (risk-monitor) — phase 9 must size for
    correlation, not isolated BABA risk.
  - Will the $140 wall *consume* (dealers absorbing) or *flip negative*
    (dealers cover and chase) on a catalyst push? (contrarian / sweep-tracker
    invalidation symmetry).
